IL177571A0 - (indol-3-yl) heterocycle derivatives as agonists of the cannabinoid cb1 receptor - Google Patents

(indol-3-yl) heterocycle derivatives as agonists of the cannabinoid cb1 receptor

Info

Publication number
IL177571A0
IL177571A0 IL177571A IL17757106A IL177571A0 IL 177571 A0 IL177571 A0 IL 177571A0 IL 177571 A IL177571 A IL 177571A IL 17757106 A IL17757106 A IL 17757106A IL 177571 A0 IL177571 A0 IL 177571A0
Authority
IL
Israel
Prior art keywords
cannabinoid
indol
agonists
receptor
heterocycle derivatives
Prior art date
Application number
IL177571A
Original Assignee
Organon Nv
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2005/050833 external-priority patent/WO2005089754A1/en
Application filed by Organon Nv, Akzo Nobel Nv filed Critical Organon Nv
Publication of IL177571A0 publication Critical patent/IL177571A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
IL177571A 2004-03-05 2006-08-17 (indol-3-yl) heterocycle derivatives as agonists of the cannabinoid cb1 receptor IL177571A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US55056304P 2004-03-05 2004-03-05
EP04100902 2004-03-05
EP04103901 2004-08-12
PCT/EP2005/050833 WO2005089754A1 (en) 2004-03-05 2005-02-28 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor

Publications (1)

Publication Number Publication Date
IL177571A0 true IL177571A0 (en) 2006-12-10

Family

ID=34960916

Family Applications (1)

Application Number Title Priority Date Filing Date
IL177571A IL177571A0 (en) 2004-03-05 2006-08-17 (indol-3-yl) heterocycle derivatives as agonists of the cannabinoid cb1 receptor

Country Status (8)

Country Link
KR (1) KR20070012389A (en)
CY (1) CY1107247T1 (en)
EC (1) ECSP066825A (en)
HK (1) HK1095097A1 (en)
HR (1) HRP20060288A2 (en)
IL (1) IL177571A0 (en)
NO (1) NO20064063L (en)
RU (1) RU2376302C2 (en)

Also Published As

Publication number Publication date
RU2376302C2 (en) 2009-12-20
RU2006135127A (en) 2008-04-10
HK1095097A1 (en) 2007-04-27
CY1107247T1 (en) 2012-11-21
NO20064063L (en) 2006-09-25
KR20070012389A (en) 2007-01-25
HRP20060288A2 (en) 2006-11-30
ECSP066825A (en) 2006-11-24

Similar Documents

Publication Publication Date Title
IL189390A0 (en) (indol-3-yl)heterocycle derivatives as agonists of the cannabinoid cb1 receptor
EP1670460A4 (en) Pyrazole derivatives as cannabinoid receptor modulators
IL186150A0 (en) Novel thiophene derivatives as sphingosine-1-1phosphate-1 receptor agonists
HK1135966A1 (en) Oxyindole derivatives as 5ht4 receptor agonists
HK1092143A1 (en) Thiazole derivatives as cannabinoid receptor modulators
EP1644335A4 (en) Tetrahydroquinoline derivatives as cannabinoid receptor modulators
ZA200605657B (en) Derivatives of N-'(1,5-diphenyl-1H-pyrazol-3-yl) sulphonamide with CB1 receptor affinity
DE602005027307D1 (en) ARYLANILINE DERIVATIVES AS AGONISTS OF THE BETA2 ADRENEER RECEPTOR
EP1790650B1 (en) Novel substituted imidazole derivatives
IL194393A0 (en) Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (cb1) receptor ligands
IL179737A0 (en) Indole derivatives as histamine receptor antagonists
AU2003275838A8 (en) Pyrrolidin-2-on derivatives as ep4 receptor agonists
IL194902A0 (en) Sulphur containing pyrazole derivatives as selective cannabinoid cb1 receptor antagonists
PL1725232T3 (en) (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor
IL191936A0 (en) 4,5-dihydro-(1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators
IL180637A0 (en) Tricyclic pyrazole derivatives as cannabinoid receptor modulators
PL1636206T3 (en) Imidazole derivatives as glutmate receptor antagonists
IL188924A0 (en) Imidazopyridine derivatives as cannabinoid receptor ligands
ZA200804926B (en) 4,5-Dihydro-(1H)-Pyrazole derivatives as cannabinoid CB1 receptor modulators
IL177571A0 (en) (indol-3-yl) heterocycle derivatives as agonists of the cannabinoid cb1 receptor
ZA200607095B (en) (Indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor
IL202299A0 (en) 4,5-dihydro-(1h)-pyrazole derivatives as cannabinoid cb1 receptor modulators
ZA200800354B (en) Imidazopyridine derivatives as cannabinoid receptor ligands
ZA200809208B (en) Sulphur containing pyrazole derivatives as selective cannabinoid CB1 receptor antagonists
IL173334A0 (en) Thiazole derivatives as cannabinoid receptor modulators